TFH2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis
Main Authors: | Yin Yao, Zhe‐Zheng Wang, Ao Huang, Yan Liu, Nan Wang, Zhi‐Chao Wang, Lin Yang, Hui‐Jun Li, Jun‐Gang Xie, Rong‐Fei Zhu, Li‐Ming Cheng, Di Yu, Zheng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.717 |
Similar Items
-
Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis
by: Yanlu Che, et al.
Published: (2023-04-01) -
SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals
by: Rongzhang He, et al.
Published: (2023-10-01) -
Group 2 Innate Lymphoid Cells in Allergic Rhinitis
by: Wang S, et al.
Published: (2024-11-01) -
New progress in pediatric allergic rhinitis
by: Miao Cheng, et al.
Published: (2024-09-01) -
Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases
by: Chao Cao, et al.
Published: (2022-05-01)